Review



human il 15 duoset elisa r d systems cat  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems human il 15 duoset elisa r d systems cat
    Human Il 15 Duoset Elisa R D Systems Cat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human il 15 duoset elisa r d systems cat/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    human il 15 duoset elisa r d systems cat - by Bioz Stars, 2026-04
    94/100 stars

    Images



    Similar Products

    94
    R&D Systems human il 15 duoset elisa r d systems cat
    Human Il 15 Duoset Elisa R D Systems Cat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human il 15 duoset elisa r d systems cat/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    human il 15 duoset elisa r d systems cat - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    95
    R&D Systems anti mouse il 1β elisa kit dy 404
    Anti Mouse Il 1β Elisa Kit Dy 404, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti mouse il 1β elisa kit dy 404/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    anti mouse il 1β elisa kit dy 404 - by Bioz Stars, 2026-04
    95/100 stars
      Buy from Supplier

    96
    R&D Systems 2024 dy 8234 05 r d systems
    2024 Dy 8234 05 R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/2024 dy 8234 05 r d systems/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    2024 dy 8234 05 r d systems - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    97
    R&D Systems elisa r d systems cat
    Figure 4. Nitric oxide biases macrophage cytokine production toward type I IFN during MRSA infection (A) <t>ELISA</t> analysis of secreted IL-1b, IFN-b, and TNF-a from mock- or 24-h MRSA-infected WT and Nos2/ BMDMs. (B) ELISA analysis of secreted IL-1b, IFN-b, and TNF-a from WT BMDM treated ± NO, donor DETA- NONOate (500 mM) for 24 h, washed with fresh media, and then mock or MRSA infected for 24 h. (C) ELISA analysis of secreted IL-1b and IFN-b after 6- or 24-h MRSA infection ± sub-toxic doses of RC inhibitors, dimethyl malonate (complex II inhibitor; 10 mM), antimycin A (complex III inhibitor; 1 mM), and piericidin A (complex I inhibitor; 100 nM). Graphs represent mean of n = 3 biological repli- cates with SD error bars. p values were calculated using two-way ANOVA with Sidak’s post-test (A– C). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
    Elisa R D Systems Cat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/elisa r d systems cat/product/R&D Systems
    Average 97 stars, based on 1 article reviews
    elisa r d systems cat - by Bioz Stars, 2026-04
    97/100 stars
      Buy from Supplier

    97
    R&D Systems il 6 elisa r d systems cat
    Figure 4. Nitric oxide biases macrophage cytokine production toward type I IFN during MRSA infection (A) <t>ELISA</t> analysis of secreted IL-1b, IFN-b, and TNF-a from mock- or 24-h MRSA-infected WT and Nos2/ BMDMs. (B) ELISA analysis of secreted IL-1b, IFN-b, and TNF-a from WT BMDM treated ± NO, donor DETA- NONOate (500 mM) for 24 h, washed with fresh media, and then mock or MRSA infected for 24 h. (C) ELISA analysis of secreted IL-1b and IFN-b after 6- or 24-h MRSA infection ± sub-toxic doses of RC inhibitors, dimethyl malonate (complex II inhibitor; 10 mM), antimycin A (complex III inhibitor; 1 mM), and piericidin A (complex I inhibitor; 100 nM). Graphs represent mean of n = 3 biological repli- cates with SD error bars. p values were calculated using two-way ANOVA with Sidak’s post-test (A– C). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
    Il 6 Elisa R D Systems Cat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il 6 elisa r d systems cat/product/R&D Systems
    Average 97 stars, based on 1 article reviews
    il 6 elisa r d systems cat - by Bioz Stars, 2026-04
    97/100 stars
      Buy from Supplier

    97
    R&D Systems il 1b elisa r d systems cat
    Figure 4. Nitric oxide biases macrophage cytokine production toward type I IFN during MRSA infection (A) <t>ELISA</t> analysis of secreted IL-1b, IFN-b, and TNF-a from mock- or 24-h MRSA-infected WT and Nos2/ BMDMs. (B) ELISA analysis of secreted IL-1b, IFN-b, and TNF-a from WT BMDM treated ± NO, donor DETA- NONOate (500 mM) for 24 h, washed with fresh media, and then mock or MRSA infected for 24 h. (C) ELISA analysis of secreted IL-1b and IFN-b after 6- or 24-h MRSA infection ± sub-toxic doses of RC inhibitors, dimethyl malonate (complex II inhibitor; 10 mM), antimycin A (complex III inhibitor; 1 mM), and piericidin A (complex I inhibitor; 100 nM). Graphs represent mean of n = 3 biological repli- cates with SD error bars. p values were calculated using two-way ANOVA with Sidak’s post-test (A– C). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
    Il 1b Elisa R D Systems Cat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il 1b elisa r d systems cat/product/R&D Systems
    Average 97 stars, based on 1 article reviews
    il 1b elisa r d systems cat - by Bioz Stars, 2026-04
    97/100 stars
      Buy from Supplier

    97
    R&D Systems dy 410
    Figure 4. Nitric oxide biases macrophage cytokine production toward type I IFN during MRSA infection (A) <t>ELISA</t> analysis of secreted IL-1b, IFN-b, and TNF-a from mock- or 24-h MRSA-infected WT and Nos2/ BMDMs. (B) ELISA analysis of secreted IL-1b, IFN-b, and TNF-a from WT BMDM treated ± NO, donor DETA- NONOate (500 mM) for 24 h, washed with fresh media, and then mock or MRSA infected for 24 h. (C) ELISA analysis of secreted IL-1b and IFN-b after 6- or 24-h MRSA infection ± sub-toxic doses of RC inhibitors, dimethyl malonate (complex II inhibitor; 10 mM), antimycin A (complex III inhibitor; 1 mM), and piericidin A (complex I inhibitor; 100 nM). Graphs represent mean of n = 3 biological repli- cates with SD error bars. p values were calculated using two-way ANOVA with Sidak’s post-test (A– C). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
    Dy 410, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dy 410/product/R&D Systems
    Average 97 stars, based on 1 article reviews
    dy 410 - by Bioz Stars, 2026-04
    97/100 stars
      Buy from Supplier

    96
    R&D Systems ifn b elisa r d systems cat
    Figure 4. Nitric oxide biases macrophage cytokine production toward type I IFN during MRSA infection (A) <t>ELISA</t> analysis of secreted IL-1b, IFN-b, and TNF-a from mock- or 24-h MRSA-infected WT and Nos2/ BMDMs. (B) ELISA analysis of secreted IL-1b, IFN-b, and TNF-a from WT BMDM treated ± NO, donor DETA- NONOate (500 mM) for 24 h, washed with fresh media, and then mock or MRSA infected for 24 h. (C) ELISA analysis of secreted IL-1b and IFN-b after 6- or 24-h MRSA infection ± sub-toxic doses of RC inhibitors, dimethyl malonate (complex II inhibitor; 10 mM), antimycin A (complex III inhibitor; 1 mM), and piericidin A (complex I inhibitor; 100 nM). Graphs represent mean of n = 3 biological repli- cates with SD error bars. p values were calculated using two-way ANOVA with Sidak’s post-test (A– C). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
    Ifn B Elisa R D Systems Cat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ifn b elisa r d systems cat/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    ifn b elisa r d systems cat - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    93
    R&D Systems systems duo set human mica dy 1300
    Figure 4. Nitric oxide biases macrophage cytokine production toward type I IFN during MRSA infection (A) <t>ELISA</t> analysis of secreted IL-1b, IFN-b, and TNF-a from mock- or 24-h MRSA-infected WT and Nos2/ BMDMs. (B) ELISA analysis of secreted IL-1b, IFN-b, and TNF-a from WT BMDM treated ± NO, donor DETA- NONOate (500 mM) for 24 h, washed with fresh media, and then mock or MRSA infected for 24 h. (C) ELISA analysis of secreted IL-1b and IFN-b after 6- or 24-h MRSA infection ± sub-toxic doses of RC inhibitors, dimethyl malonate (complex II inhibitor; 10 mM), antimycin A (complex III inhibitor; 1 mM), and piericidin A (complex I inhibitor; 100 nM). Graphs represent mean of n = 3 biological repli- cates with SD error bars. p values were calculated using two-way ANOVA with Sidak’s post-test (A– C). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
    Systems Duo Set Human Mica Dy 1300, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/systems duo set human mica dy 1300/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    systems duo set human mica dy 1300 - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    Image Search Results


    Figure 4. Nitric oxide biases macrophage cytokine production toward type I IFN during MRSA infection (A) ELISA analysis of secreted IL-1b, IFN-b, and TNF-a from mock- or 24-h MRSA-infected WT and Nos2/ BMDMs. (B) ELISA analysis of secreted IL-1b, IFN-b, and TNF-a from WT BMDM treated ± NO, donor DETA- NONOate (500 mM) for 24 h, washed with fresh media, and then mock or MRSA infected for 24 h. (C) ELISA analysis of secreted IL-1b and IFN-b after 6- or 24-h MRSA infection ± sub-toxic doses of RC inhibitors, dimethyl malonate (complex II inhibitor; 10 mM), antimycin A (complex III inhibitor; 1 mM), and piericidin A (complex I inhibitor; 100 nM). Graphs represent mean of n = 3 biological repli- cates with SD error bars. p values were calculated using two-way ANOVA with Sidak’s post-test (A– C). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.

    Journal: Cell reports

    Article Title: Type I interferon governs immunometabolic checkpoints that coordinate inflammation during Staphylococcal infection.

    doi: 10.1016/j.celrep.2024.114607

    Figure Lengend Snippet: Figure 4. Nitric oxide biases macrophage cytokine production toward type I IFN during MRSA infection (A) ELISA analysis of secreted IL-1b, IFN-b, and TNF-a from mock- or 24-h MRSA-infected WT and Nos2/ BMDMs. (B) ELISA analysis of secreted IL-1b, IFN-b, and TNF-a from WT BMDM treated ± NO, donor DETA- NONOate (500 mM) for 24 h, washed with fresh media, and then mock or MRSA infected for 24 h. (C) ELISA analysis of secreted IL-1b and IFN-b after 6- or 24-h MRSA infection ± sub-toxic doses of RC inhibitors, dimethyl malonate (complex II inhibitor; 10 mM), antimycin A (complex III inhibitor; 1 mM), and piericidin A (complex I inhibitor; 100 nM). Graphs represent mean of n = 3 biological repli- cates with SD error bars. p values were calculated using two-way ANOVA with Sidak’s post-test (A– C). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.

    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Lysostaphin Sigma Cat#L7386 Critical commercial assays Cut & Run kit Cell Signaling Cat#86652 Lactate assay Cayman Chemical Cat#600450 Greiss reagent Abcam Cat#ab234044 Mito Stress Test Agilent Cat#103015-100 LookOut Mycoplasma PCR Detection Kit Sigma Cat#MP0035 MitoTracker Green Thermo Fisher Scientific Cat#M7514 MitoTracker Deep Red Thermo Fisher Scientific Cat#M22426 Propidium iodide Bio-Rad Cat#1351101 Hoechst Thermo Fisher Scientific Cat#H3570 DAPI Thermo Fisher Scientific Cat#EN62248 PowerUP SYBR Green PCR master mix Thermo Fisher Scientific Cat#A25742 RNAeasy Plus Mini kit Qiagen Cat#74134 iScript cDNA synthesis kit Bio-Rad Cat#1708890 BioMasher II homogenizers Thermo Fisher Scientific Cat#50-136-7690 Halt protease and phosphatase inhibitor cocktail Thermo Fisher Scientific Cat#78440 RevertTM 700 Total Protein Stain for Western Blot Normalization LI-COR Cat#926-11011 TNF-a ELISA R&D Systems Cat#DY 410 IL-6 ELISA R&D Systems Cat#DY 406 IL-1b ELISA R&D Systems Cat#DY 401 IFN-b ELISA R&D Systems Cat#DY 8234-05 MPO ELISA Abcam Cat#ab155458 Bio-Rad Protein Assay (Bradford assay) Bio-Rad Cat#5000001 TRIzolTM Reagent Thermo Fisher Scientific Cat#15596026 NativePAGETM Sample Prep Kit Thermo Fisher Scientific Cat#BN2008 NativeMarkTM Unstained Protein Standard Thermo Fisher Scientific Cat#LC0725 NativePAGETM 4 to 16%, Bis-Tris, 1.0 mm, Mini Protein Gels Thermo Fisher Scientific Cat#BN1002BOX NativePAGETM Running Buffer Kit Thermo Fisher Scientific Cat#BN2007 NuPAGETM Transfer Buffer Thermo Fisher Scientific Cat#NP0006 4x Laemmli Sample Buffer Bio-Rad Cat#1610747 IGEPAL CA-630 Sigma Cat#I8896 4–20% Mini-PROTEAN TGXTM Precast Protein Gels Bio-Rad Cat#4561096 Deposited data Targeted metabolomics analysis of WT and IFNAR1 deficient murine bone marrow-derived macrophages following methicillin-resistant Staphylococcus aureus infection [Dataset] This paper https://doi.org/10.7302/h15v-j558 RNAseq analysis of Tlr2/4/9 / iBMDM and paired WT controls [Dataset] This paper GEO accession # GSE271727 Experimental models: Cell lines Tlr2/4/9 / iBMDM and paired WT controls Derived in our lab from mice obtained from the laboratory of Dr. Tod Merkel, FDA20 Ifnar1 / iBMDM and paired WT controls Derived in our lab from mice obtained from the Jackson Laboratory strain #010830 (Continued on next page) Cell Reports 43, 114607, August 27, 2024 19

    Techniques: Infection, Enzyme-linked Immunosorbent Assay

    Figure 4. Nitric oxide biases macrophage cytokine production toward type I IFN during MRSA infection (A) ELISA analysis of secreted IL-1b, IFN-b, and TNF-a from mock- or 24-h MRSA-infected WT and Nos2/ BMDMs. (B) ELISA analysis of secreted IL-1b, IFN-b, and TNF-a from WT BMDM treated ± NO, donor DETA- NONOate (500 mM) for 24 h, washed with fresh media, and then mock or MRSA infected for 24 h. (C) ELISA analysis of secreted IL-1b and IFN-b after 6- or 24-h MRSA infection ± sub-toxic doses of RC inhibitors, dimethyl malonate (complex II inhibitor; 10 mM), antimycin A (complex III inhibitor; 1 mM), and piericidin A (complex I inhibitor; 100 nM). Graphs represent mean of n = 3 biological repli- cates with SD error bars. p values were calculated using two-way ANOVA with Sidak’s post-test (A– C). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.

    Journal: Cell reports

    Article Title: Type I interferon governs immunometabolic checkpoints that coordinate inflammation during Staphylococcal infection.

    doi: 10.1016/j.celrep.2024.114607

    Figure Lengend Snippet: Figure 4. Nitric oxide biases macrophage cytokine production toward type I IFN during MRSA infection (A) ELISA analysis of secreted IL-1b, IFN-b, and TNF-a from mock- or 24-h MRSA-infected WT and Nos2/ BMDMs. (B) ELISA analysis of secreted IL-1b, IFN-b, and TNF-a from WT BMDM treated ± NO, donor DETA- NONOate (500 mM) for 24 h, washed with fresh media, and then mock or MRSA infected for 24 h. (C) ELISA analysis of secreted IL-1b and IFN-b after 6- or 24-h MRSA infection ± sub-toxic doses of RC inhibitors, dimethyl malonate (complex II inhibitor; 10 mM), antimycin A (complex III inhibitor; 1 mM), and piericidin A (complex I inhibitor; 100 nM). Graphs represent mean of n = 3 biological repli- cates with SD error bars. p values were calculated using two-way ANOVA with Sidak’s post-test (A– C). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.

    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Lysostaphin Sigma Cat#L7386 Critical commercial assays Cut & Run kit Cell Signaling Cat#86652 Lactate assay Cayman Chemical Cat#600450 Greiss reagent Abcam Cat#ab234044 Mito Stress Test Agilent Cat#103015-100 LookOut Mycoplasma PCR Detection Kit Sigma Cat#MP0035 MitoTracker Green Thermo Fisher Scientific Cat#M7514 MitoTracker Deep Red Thermo Fisher Scientific Cat#M22426 Propidium iodide Bio-Rad Cat#1351101 Hoechst Thermo Fisher Scientific Cat#H3570 DAPI Thermo Fisher Scientific Cat#EN62248 PowerUP SYBR Green PCR master mix Thermo Fisher Scientific Cat#A25742 RNAeasy Plus Mini kit Qiagen Cat#74134 iScript cDNA synthesis kit Bio-Rad Cat#1708890 BioMasher II homogenizers Thermo Fisher Scientific Cat#50-136-7690 Halt protease and phosphatase inhibitor cocktail Thermo Fisher Scientific Cat#78440 RevertTM 700 Total Protein Stain for Western Blot Normalization LI-COR Cat#926-11011 TNF-a ELISA R&D Systems Cat#DY 410 IL-6 ELISA R&D Systems Cat#DY 406 IL-1b ELISA R&D Systems Cat#DY 401 IFN-b ELISA R&D Systems Cat#DY 8234-05 MPO ELISA Abcam Cat#ab155458 Bio-Rad Protein Assay (Bradford assay) Bio-Rad Cat#5000001 TRIzolTM Reagent Thermo Fisher Scientific Cat#15596026 NativePAGETM Sample Prep Kit Thermo Fisher Scientific Cat#BN2008 NativeMarkTM Unstained Protein Standard Thermo Fisher Scientific Cat#LC0725 NativePAGETM 4 to 16%, Bis-Tris, 1.0 mm, Mini Protein Gels Thermo Fisher Scientific Cat#BN1002BOX NativePAGETM Running Buffer Kit Thermo Fisher Scientific Cat#BN2007 NuPAGETM Transfer Buffer Thermo Fisher Scientific Cat#NP0006 4x Laemmli Sample Buffer Bio-Rad Cat#1610747 IGEPAL CA-630 Sigma Cat#I8896 4–20% Mini-PROTEAN TGXTM Precast Protein Gels Bio-Rad Cat#4561096 Deposited data Targeted metabolomics analysis of WT and IFNAR1 deficient murine bone marrow-derived macrophages following methicillin-resistant Staphylococcus aureus infection [Dataset] This paper https://doi.org/10.7302/h15v-j558 RNAseq analysis of Tlr2/4/9 / iBMDM and paired WT controls [Dataset] This paper GEO accession # GSE271727 Experimental models: Cell lines Tlr2/4/9 / iBMDM and paired WT controls Derived in our lab from mice obtained from the laboratory of Dr. Tod Merkel, FDA20 Ifnar1 / iBMDM and paired WT controls Derived in our lab from mice obtained from the Jackson Laboratory strain #010830 (Continued on next page) Cell Reports 43, 114607, August 27, 2024 19

    Techniques: Infection, Enzyme-linked Immunosorbent Assay

    Figure 4. Nitric oxide biases macrophage cytokine production toward type I IFN during MRSA infection (A) ELISA analysis of secreted IL-1b, IFN-b, and TNF-a from mock- or 24-h MRSA-infected WT and Nos2/ BMDMs. (B) ELISA analysis of secreted IL-1b, IFN-b, and TNF-a from WT BMDM treated ± NO, donor DETA- NONOate (500 mM) for 24 h, washed with fresh media, and then mock or MRSA infected for 24 h. (C) ELISA analysis of secreted IL-1b and IFN-b after 6- or 24-h MRSA infection ± sub-toxic doses of RC inhibitors, dimethyl malonate (complex II inhibitor; 10 mM), antimycin A (complex III inhibitor; 1 mM), and piericidin A (complex I inhibitor; 100 nM). Graphs represent mean of n = 3 biological repli- cates with SD error bars. p values were calculated using two-way ANOVA with Sidak’s post-test (A– C). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.

    Journal: Cell reports

    Article Title: Type I interferon governs immunometabolic checkpoints that coordinate inflammation during Staphylococcal infection.

    doi: 10.1016/j.celrep.2024.114607

    Figure Lengend Snippet: Figure 4. Nitric oxide biases macrophage cytokine production toward type I IFN during MRSA infection (A) ELISA analysis of secreted IL-1b, IFN-b, and TNF-a from mock- or 24-h MRSA-infected WT and Nos2/ BMDMs. (B) ELISA analysis of secreted IL-1b, IFN-b, and TNF-a from WT BMDM treated ± NO, donor DETA- NONOate (500 mM) for 24 h, washed with fresh media, and then mock or MRSA infected for 24 h. (C) ELISA analysis of secreted IL-1b and IFN-b after 6- or 24-h MRSA infection ± sub-toxic doses of RC inhibitors, dimethyl malonate (complex II inhibitor; 10 mM), antimycin A (complex III inhibitor; 1 mM), and piericidin A (complex I inhibitor; 100 nM). Graphs represent mean of n = 3 biological repli- cates with SD error bars. p values were calculated using two-way ANOVA with Sidak’s post-test (A– C). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.

    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Lysostaphin Sigma Cat#L7386 Critical commercial assays Cut & Run kit Cell Signaling Cat#86652 Lactate assay Cayman Chemical Cat#600450 Greiss reagent Abcam Cat#ab234044 Mito Stress Test Agilent Cat#103015-100 LookOut Mycoplasma PCR Detection Kit Sigma Cat#MP0035 MitoTracker Green Thermo Fisher Scientific Cat#M7514 MitoTracker Deep Red Thermo Fisher Scientific Cat#M22426 Propidium iodide Bio-Rad Cat#1351101 Hoechst Thermo Fisher Scientific Cat#H3570 DAPI Thermo Fisher Scientific Cat#EN62248 PowerUP SYBR Green PCR master mix Thermo Fisher Scientific Cat#A25742 RNAeasy Plus Mini kit Qiagen Cat#74134 iScript cDNA synthesis kit Bio-Rad Cat#1708890 BioMasher II homogenizers Thermo Fisher Scientific Cat#50-136-7690 Halt protease and phosphatase inhibitor cocktail Thermo Fisher Scientific Cat#78440 RevertTM 700 Total Protein Stain for Western Blot Normalization LI-COR Cat#926-11011 TNF-a ELISA R&D Systems Cat#DY 410 IL-6 ELISA R&D Systems Cat#DY 406 IL-1b ELISA R&D Systems Cat#DY 401 IFN-b ELISA R&D Systems Cat#DY 8234-05 MPO ELISA Abcam Cat#ab155458 Bio-Rad Protein Assay (Bradford assay) Bio-Rad Cat#5000001 TRIzolTM Reagent Thermo Fisher Scientific Cat#15596026 NativePAGETM Sample Prep Kit Thermo Fisher Scientific Cat#BN2008 NativeMarkTM Unstained Protein Standard Thermo Fisher Scientific Cat#LC0725 NativePAGETM 4 to 16%, Bis-Tris, 1.0 mm, Mini Protein Gels Thermo Fisher Scientific Cat#BN1002BOX NativePAGETM Running Buffer Kit Thermo Fisher Scientific Cat#BN2007 NuPAGETM Transfer Buffer Thermo Fisher Scientific Cat#NP0006 4x Laemmli Sample Buffer Bio-Rad Cat#1610747 IGEPAL CA-630 Sigma Cat#I8896 4–20% Mini-PROTEAN TGXTM Precast Protein Gels Bio-Rad Cat#4561096 Deposited data Targeted metabolomics analysis of WT and IFNAR1 deficient murine bone marrow-derived macrophages following methicillin-resistant Staphylococcus aureus infection [Dataset] This paper https://doi.org/10.7302/h15v-j558 RNAseq analysis of Tlr2/4/9 / iBMDM and paired WT controls [Dataset] This paper GEO accession # GSE271727 Experimental models: Cell lines Tlr2/4/9 / iBMDM and paired WT controls Derived in our lab from mice obtained from the laboratory of Dr. Tod Merkel, FDA20 Ifnar1 / iBMDM and paired WT controls Derived in our lab from mice obtained from the Jackson Laboratory strain #010830 (Continued on next page) Cell Reports 43, 114607, August 27, 2024 19

    Techniques: Infection, Enzyme-linked Immunosorbent Assay